Marvell Rises 3% After Monday’s 7% Drop: Is the Lumentum Deal Still Worth the Dilution Risk?
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A sharp Monday selloff and a pending optical acquisition have put Marvell Technology (NASDAQ:MRVL | MRVL Price Prediction) at the center of the AI chip debate. Marvell shares trade at $149.06, up 3%. That rebound follows a 7% drop on Monday to a $145.36 close, and it doesn’t settle what the company’s pending optical deal could cost shareholders.
The gain lines up with a 13F filing, the quarterly holdings report large money managers send to the Securities and Exchange Commission, showing Citadel sharply increased its Marvell stake. Those filings capture positions as of the quarter’s end on September 30, so they don’t show what Citadel owns now.
Why Marvell Fell Harder Than Chip Peers on Monday
Chip stocks generally sold off on November 16[1] ahead of NVIDIA (NASDAQ:NVDA) results and Anthropic’s expected trading debut. The S&P 500 slid alongside them, and Marvell dropped 7%.
Marvell fell even though it announced a collaboration that same day with Penguin Solutions (NASDAQ:PENG). The partnership covers AI memory and photonic memory technology for data center inference. Selling that overwhelmed fresh product news points to broad risk appetite as the main force behind Marvell’s Monday slide.
Broadcom Keeps Pace While NVIDIA Slips
Broadcom (NASDAQ:AVGO) stock is at $340.40, up 2%. That advance is a touch smaller than Marvell’s rebound, and it keeps Broadcom moving in the same direction as Marvell.
NVIDIA stock is at $155.41, down 0.5%, ahead of its upcoming earnings report. The chipmaker is the one name in this group trading lower, which cuts against the idea of a broad chip rebound alongside Marvell.
How Marvell’s Business Model Stands Apart From Broadcom and NVIDIA
Marvell is a fabless chip designer focused on custom silicon and the data center connectivity that links AI systems, from optics to Ethernet switches. Acquisitions of Celestial AI and XConn Technologies, which closed in February, pushed Marvell deeper into photonic and chiplet interconnect.
Broadcom pairs custom AI accelerators and networking chips with a large infrastructure software business that includes VMware, while NVIDIA sells full accelerated computing platforms, wrapping its processors, networking and systems in the CUDA software ecosystem. Against those two, Marvell is the more concentrated play. It targets the plumbing inside AI data centers (we pulled together seven companies driving that expansion, from power to cooling to networking, in a free report you can grab here).
Weighing Lumentum’s Optical Scale Against Marvell Dilution
Lumentum Holdings (NASDAQ:LITE) stock is at $572.55, up 5%, after a Reuters report that the U.S. is moving ahead with curbs on imports of new Chinese optical transceivers. A B. Riley note said Lumentum’s value now depends on how Marvell stock trades, which puts the deal’s dilution question front and center.
The bulls see a deal that would add scale in optical interconnect, an area Marvell management already ranks among its strongest businesses. Speaking on the August 27[2] earnings call, the company’s chief executive said “Connectivity clearly is a driver,”[3] adding that the business “continues to be absolutely on fire.” The bears point to share dilution, regulatory review and the work of integrating a large optical business.
Equity commitments are already on Marvell’s books. The company issued $2 billion of Series A Convertible Preferred Stock on March 31. It also gave a key hyperscaler a warrant to acquire up to 7%[2] of its shares tied to revenue milestones. To address that, the chief financial officer stated on the same call, “we intend to continue repurchasing shares to manage dilution.”[3]
Marvell Technology’s data center segment made up 79%[1] of revenue in Q2 FY2027 and grew 46% from a year earlier, per its second-quarter results. Marvell Technology’s chief executive guided for data center revenue growth of “roughly 75% year-over-year”[1] for the following quarter.
What Comes Next for Marvell and the Lumentum Deal
Marvell’s upcoming earnings will show whether custom silicon and connectivity demand hold up while the Lumentum deal is pending. A stronger Marvell share price could ease dilution concerns, since the B. Riley view links Lumentum’s value to Marvell stock.
Further chip weakness, a drawn-out regulatory review or a rough integration would cut the other way for existing owners. Those risks could weigh on Marvell stock until the Lumentum deal review concludes.
Contact [email protected] for any questions or corrections.







